8.88
Ardent Health Inc stock is traded at $8.88, with a volume of 37,835.
It is down -1.67% in the last 24 hours and down -4.93% over the past month.
Ardent Health Inc is a provider of healthcare in growing mid-sized urban communities across the U.S. With a focus on people and investments in services and technologies, Ardent is passionate about making healthcare easier to access.
See More
Previous Close:
$9.04
Open:
$8.95
24h Volume:
37,835
Relative Volume:
0.09
Market Cap:
$1.27B
Revenue:
$6.33B
Net Income/Loss:
$296.76M
P/E Ratio:
6.1521
EPS:
1.4434
Net Cash Flow:
$154.89M
1W Performance:
-7.79%
1M Performance:
-4.93%
6M Performance:
-33.01%
1Y Performance:
-37.40%
Ardent Health Inc Stock (ARDT) Company Profile
Name
Ardent Health Inc
Sector
Industry
Phone
(615) 296-3000
Address
340 SEVEN SPRINGS WAY, BRENTWOOD
Compare ARDT vs HCA, THC, FMS, ENSG, UHS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ARDT
Ardent Health Inc
|
8.87 | 1.29B | 6.33B | 296.76M | 154.89M | 1.4434 |
|
HCA
Hca Healthcare Inc
|
533.83 | 120.23B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
237.99 | 20.65B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.79 | 12.82B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
ENSG
Ensign Group Inc
|
209.38 | 12.18B | 4.11B | 239.98M | 193.10M | 4.12 |
|
UHS
Universal Health Services Inc
|
185.64 | 11.39B | 16.08B | 1.20B | 1.06B | 17.82 |
Ardent Health Inc Stock (ARDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-17-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-14-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-14-25 | Initiated | Goldman | Neutral |
| Sep-10-25 | Initiated | UBS | Buy |
| Jul-16-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| Nov-06-24 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-12-24 | Initiated | BofA Securities | Buy |
| Aug-12-24 | Initiated | Citigroup | Buy |
| Aug-12-24 | Initiated | JP Morgan | Neutral |
| Aug-12-24 | Initiated | Leerink Partners | Outperform |
| Aug-12-24 | Initiated | Loop Capital | Buy |
| Aug-12-24 | Initiated | Mizuho | Outperform |
| Aug-12-24 | Initiated | Morgan Stanley | Overweight |
| Aug-12-24 | Initiated | RBC Capital Mkts | Outperform |
| Aug-12-24 | Initiated | Stephens | Overweight |
| Aug-12-24 | Initiated | Truist | Buy |
View All
Ardent Health Inc Stock (ARDT) Latest News
Ardent Health Earnings Call: Strength Today, Caution Ahead - TipRanks
Class Action Filed Against Ardent Health, Inc. (ARDT)March 9, 2026 Deadline to JoinContact The Gross Law Firm - marketscreener.com
RBC Capital lowers Ardent Health stock price target on revised estimates - Investing.com
Levi & Korsinsky Notifies Ardent Health, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – ARDT - GlobeNewswire
ARDT CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Ardent Investors of the Securities Class Action Lawsuit Deadline on March 9, 2026 - 巴士的報
ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
KeyBanc reiterates Sector Weight on Ardent Health stock - Investing.com
Assessing Ardent Health (ARDT) Valuation As Shares Face Recent Short Term Weakness - Yahoo Finance
ARDENT HEALTH FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Ardent ... - Bluefield Daily Telegraph
ARDENT HEALTH FINAL DEADLINE ALERT: Bragar Eagel & Squire, - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Ardent Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
EDR IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Endeavor Group Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 18 Deadline in Securities Class Action - GlobeNewswire Inc.
ARDT FINAL DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Ardent Health, Inc. Investors ... - Bluefield Daily Telegraph
ARDT FINAL DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Ardent Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 9 Deadline in Securities Class Action - GlobeNewswire Inc.
ARDT 48 HOUR DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ardent Health (ARDT) Investors of Securities Class Action Deadline on March 9, 2026 - TMX Newsfile
$ARDT Class Reminder: Ardent Health Investors Reminded of the Monday March 9 Securities Class Action Deadline – Investors with Losses Urged to Contact BFA Law - GlobeNewswire
$DRVN Investigation News: Driven Brands Investors Notified of the Ongoing Securities Investigation – Investors with Losses Urged to Contact BFA Law - GlobeNewswire Inc.
Risk Check: Is Ardent Health Inc. stock worth buying before Fed actionWeekly Stock Summary & Reliable Breakout Forecasts - Naître et grandir
ARDT Deadline: ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit - The Norfolk Daily News
Ardent Health 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Ardent Health, Inc.ARDT - Business Wire
Investors who lost money on Ardent Health, Inc. (ARDT) should contact The Gross Law Firm about ... - Bluefield Daily Telegraph
Investors who lost money on Ardent Health, Inc. (ARDT) - GlobeNewswire
Ardent Health Partners: Cost Efficiencies Balance Utilization Headwinds, Justifying a Hold Rating - TipRanks
Expert Outlook: Ardent Health Through The Eyes Of 4 Analysts - Benzinga
Ardent Health (NYSE:ARDT) Given New $15.00 Price Target at Leerink Partners - MarketBeat
Deadline Soon: Ardent Health, Inc. (ARDT) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - The AI Journal
ARDT 4-DAY DEADLINE ALERT: Ardent Health Facing Securities Class Action Over Alleged $97M Accounting Shock and "180-Day Cliff" ReservesHagens Berman - The Malaysian Reserve
Leerink Partners Lowers Price Target for ARDT, Maintains Outperf - GuruFocus
Ardent Health Q4 Earnings Call Highlights - MarketBeat
Ardent Health outlines $485M-$535M 2026 EBITDA target through impact program savings while expanding AI-driven care - MSN
Ardent Health Services (ARDT) Margin Compression To 2.1% Challenges Bullish Earnings Growth Narratives - simplywall.st
ARDT DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Ardent Health, Inc. Investors to ... - Bluefield Daily Telegraph
ARDT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardent Health, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardent Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesARDT - PR Newswire
Ardent Health (ARDT) Q4 2025 Earnings Transcript - AOL.com
Ardent Health (NYSE:ARDT) Shares Gap Down After Earnings Miss - MarketBeat
Earnings call transcript: Ardent Health Q4 2025 shows strong annual growth, stock down - Investing.com Canada
Ardent Health Partners, LLC Q4 2025 Earnings Call Summary - Yahoo Finance
$ARDT Stock Drop: Lose Money when Ardent Health Stock Fell 33% Amid Collectability Issues? Contact BFA Law before March 9 Class Action Deadline - marketscreener.com
UPCOMING DEADLINE: Ardent Health, Inc. (ARDT) Securities Fraud Class ActionMarch 9, 2026 Lead Plaintiff Deadline - The Malaysian Reserve
Ardent Health Inc (ARDT) Q4 2025 Earnings Report Preview: What T - GuruFocus
Ardent Health Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
Ardent Health, Inc. (ARDT) Lags Q4 Earnings and Revenue Estimates - Bitget
Ardent Health shaeres slide 11% on weak 2026 guidance despite Q4 beat - Investing.com
MONDAY DEADLINE: Ardent Health, Inc. Investors with Significant - GuruFocus
Ardent Health Q4 Earnings, Revenue Drop; Shares Fall After Hours - marketscreener.com
Ardent Health (NYSE:ARDT) Issues FY 2026 Earnings Guidance - MarketBeat
Ardent Health shaeres slide 11% on weak 2026 guidance despite Q4 beat By Investing.com - Investing.com Canada
Earnings Summary: Ardent Health Q4 - Benzinga
ARDT: 2025 delivered strong revenue and EBITDA growth, with FY26 guidance signaling further gains - TradingView
Ardent Health Q4 adjusted EBITDA beats estimates, driven by expense optimization - TradingView
Ardent Health Inc Stock (ARDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):